Producing proteins in transgenic plants and animals.
The requirement for large quantities of therapeutic proteins has fueled interest in the production of recombinant proteins in plants and animals. The first commercial products to be made in this way have experienced much success, and it is predicted that in the future a plethora of protein products will be made using these 'natural' bioreactors.
Larrick
J W
JW
Planet Biotechnology, Inc., 2438 Wyandotte Street, Mountain View, CA 94043, USA. jwlarrick@aol.com
Thomas
D W
DW
D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics / Q000378:metabolism*; D000990:Antithrombin III / Q000096:biosynthesis* / Q000235:genetics; D019149:Bioreactors; D006031:Glycosylation; D030821:Plants, Genetically Modified / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000302:isolation & purification*; D013812:Therapeutics; D022462:Vaccines, Edible / Q000096:biosynthesis* / Q000235:genetics
D011994:Recombinant Proteins; D022462:Vaccines, Edible; D000990:Antithrombin III